Through an integrative analysis with bioinformatics methods, we identified a nine-lncRNA signature (including MIR497HG, LINC00968, NALCN-AS1, LINC02321, RNF144A-AS1, MNX1-AS1, FLJ22447, LINC01956, and FLJ42969) to predict the OS and prognosis of bladder cancer patients. Here, NALCN is linked to urinary bladder carcinoma.